Africure Pharmaceuticals is a small African generics maker listed in Mauritius. It is profitable at the operating level, but thin margins and uneven government orders keep the bottom line fragile. Full nameAfricure Pharmaceuticals Ltd Tickers / exchangeAFRP.SEM — Stock Exchange of Mauritius HeadquartersMauritius (city not published in available sources) SectorPharmaceuticals — generic medicines EmployeesNot published in available sources Market valueNot published in available sources Yearly salesUSD 26.8 million (FY ended 31 March 2024) Net profitLoss of USD 405,160 (FY2024) Net marginNegative — about -1.5% (our calculation) Return on equityNegative — …
Company Intelligence — Institutional Access
This dossier is part of our Company Intelligence database.
Full profiles, exchange dossiers and the regional intelligence briefs are available to institutional subscribers. Professional from US$490/year, Corporate US$1,450, Institutional US$3,900.
See institutional access →Already a subscriber? Log in.
Part of LatAm Company Intelligence
This company profile belongs to The Rio Times' research on every listed company and exchange in Latin America and the Caribbean. Browse the full intelligence hub →
Not ready to buy? Try Company Intelligence free for 14 days →
Editorial responsibility: Matthias Camenzind, Editor-in-Chief · Editorial standards · Report an error
Read More from The Rio Times
The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →